Testing an MBI for Smoking Cessation and Alcohol Use Among Cancer Survivors
Key facts
- Who runs it
- H. Lee Moffitt Cancer Center and Research Institute
- Where
- Tampa, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 600 people, planned
- Started
- 15 May 2026
- Expected to end
- Dec 2029
- Type of study
- Interventional, 2 groups
- Treatments tested
- Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA)
- Quitline Support
- Record updated
- 18 May 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- ≥18 years old
- History of a cancer diagnosis at any point in lifetime
- Smoked ≥1 cigarette/day in past month
- At least one binge drinking episode in past month or exceeds weekly drinking limits
- Motivated to quit smoking and modify alcohol use in next 30 days
- Valid home address in Florida
- English-speaking, reading, and writing ability
Who cannot take part
- Current use of tobacco cessation medication or other treatments to quit smoking
- Active psychotic disorder
- History of severe alcohol withdrawal
- Pregnancy or lactation
- End-of-life or hospice care
- Household member already enrolled
Where in United States
- Moffitt Cancer CenterTampa, United StatesContact: Christine Vinci, PhD (principal investigator)Taking people
About the trial
What the trial wants to find out
This study will examine the efficacy of Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) compared to standard care among cancer survivors who smoke cigarettes and engage in at-risk alcohol use. Investigators will evaluate implementation outcomes through structured stakeholder interviews across medical centers, cancer-focused organizations, and community-based programs in Florida, and will conduct a cost-assessment and an incremental cost-effectiveness analysis of the two conditions.
The 2 groups in the trial
- Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA)Treatment being tested
Participants randomized to this condition will receive a mindfulness-based intervention delivered in a group format via Zoom.
- Quitline SupportTreatment being tested
Participants randomized to this condition will be connected to the Florida Tobacco Quitline for smoking cessation services, as well as receive community referrals for alcohol use treatment.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Smoking Cessation and Alcohol Use Among Cancer Survivors: Investigating the Efficacy of a Mindfulness-Based Intervention
- Record updated
- 18 May 2026